544 related articles for article (PubMed ID: 31509261)
1. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.
Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM
Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
3. SNHG16/miR-605-3p/TRAF6/NF-κB feedback loop regulates hepatocellular carcinoma metastasis.
Hu YL; Feng Y; Chen YY; Liu JZ; Su Y; Li P; Huang H; Mao QS; Xue WJ
J Cell Mol Med; 2020 Jul; 24(13):7637-7651. PubMed ID: 32436333
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
6. Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495-3p/TRAF6 through the NF-κB pathway.
Xu L; Cao H; Xu P; Nie M; Zhao C
Autoimmunity; 2022 Feb; 55(1):52-64. PubMed ID: 34730059
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma.
Wang S; Qi Y; Gao X; Qiu W; Liu Q; Guo X; Qian M; Chen Z; Zhang Z; Wang H; Xu J; Xue H; Guo X; Zhang P; Zhao R; Li G
Cell Death Dis; 2020 Mar; 11(3):168. PubMed ID: 32127518
[TBL] [Abstract][Full Text] [Related]
8. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
9. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway.
He X; Zheng Y; Liu S; Shi S; Liu Y; He Y; Zhang C; Zhou X
J Cell Physiol; 2018 Mar; 233(3):2476-2488. PubMed ID: 28771774
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1.
Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T
Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
12. miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.
Lu Y; Hippen KL; Lemire AL; Gu J; Wang W; Ni X; Ranganathan P; Levine BL; Riley JL; June CH; Turka LA; Munn DH; Garzon R; Lu L; Blazar BR
Blood; 2016 Sep; 128(10):1424-35. PubMed ID: 27485827
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol protects BV2 mouse microglial cells against LPS-induced inflammatory injury by altering the miR-146a-5p/TRAF6/NF-κB axis.
Ge YT; Zhong AQ; Xu GF; Lu Y
Immunopharmacol Immunotoxicol; 2019 Oct; 41(5):549-557. PubMed ID: 31530042
[No Abstract] [Full Text] [Related]
15. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
16. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
[TBL] [Abstract][Full Text] [Related]
17. IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1).
Du J; He Y; Li P; Wu W; Chen Y; Ruan H
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1111-1119. PubMed ID: 29693201
[TBL] [Abstract][Full Text] [Related]
18. miR-509-5p anti-infection response for mycoplasma pneumonia in sheep by targeting NF-κB pathway.
Zhu M; Cao S; Zheng W; Zhai M; Wang M; Blair HT; Morris ST; Zhang H; Zhao Z
Vet Immunol Immunopathol; 2021 Aug; 238():110275. PubMed ID: 34153741
[TBL] [Abstract][Full Text] [Related]
19. Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway.
Kong Y; Zhang L; Huang Y; He T; Zhang L; Zhao X; Zhou X; Zhou D; Yan Y; Zhou J; Xie H; Zhou L; Zheng S; Wang W
Cancer Lett; 2017 Oct; 407():76-83. PubMed ID: 28823960
[TBL] [Abstract][Full Text] [Related]
20. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]